<p>, /PRNewswire/ --</p>
<p>原因：羅森律師事務所是一家全球投資者權益律師事務所，提醒在 2024 年 12 月 4 日至 2025 年 9 月 9 日期間（包括這兩天）購買和收購 Synopsys, Inc.（納斯達克：SNPS）證券的投資者，注意 2025 年 12 月 30 日的重要首席原告截止日期。</p>
<p>那麼，接下來該怎麼辦：如果您購買了 Synopsys 證券，您可能有權在不支付任何自付費用或成本的情況下，通過風險代理安排獲得賠償。</p>
<p>下一步該做什麼：要加入 Synopsys 集體訴訟，請訪問 https://rosenlegal.com/submit-form/?case_id=44981 https://rosenlegal.com/submit-form/?case_id=39889 或撥打無障礙電話 866-767-3653 聯繫 Phillip Kim 律師，或發送電子郵件至 [email protected] 獲取有關集體訴訟的信息。集體訴訟已被提起。如果您希望擔任首席原告，必須在 2025 年 12 月 30 日之前向法院提出申請。首席原告是代表其他集體成員指導訴訟的代表方。</p>
<p>為什麼選擇羅森律師事務所：我們鼓勵投資者選擇在領導角色上有成功記錄的合格律師事務所。通常，發佈通知的事務所沒有相應的經驗、資源或任何有意義的同行認可。這些事務所中的許多並不真正進行證券集體訴訟，而只是作為中介，將客户轉介或與實際進行訴訟的律師事務所合作。選擇律師時要明智。羅森律師事務所代表全球投資者，專注於證券集體訴訟和股東衍生訴訟。羅森律師事務所曾獲得針對一家中國公司的最大證券集體訴訟和解。在 2017 年，羅森律師事務所被 ISS 證券集體訴訟服務評為證券集體訴訟和解數量第一的律師事務所。自 2013 年以來，該事務所每年均排名前四，併為投資者追回了數億美元。僅在 2019 年，該事務所就為投資者爭取了超過 4.38 億美元。在 2020 年，創始合夥人 Laurence Rosen 被 law360 評選為原告律師界的巨頭。該事務所的許多律師已獲得 Lawdragon 和 Super Lawyers 的認可。</p>
<p>案件詳情：根據訴訟， defendants 在集體訴訟期間做出了實質性虛假和/或誤導性陳述，並未披露有關公司業務、運營和前景的重大不利事實。具體而言，被告未向投資者披露：（1）Synopsys 對人工智能客户的關注增加，導致其設計 IP 業務的經濟狀況惡化的程度；（2）因此，“某些路線圖和資源決策” 不太可能 “產生預期結果”；（3）上述情況對財務結果產生了實質性負面影響；（4）因此，被告對 Synopsys 的業務、運營和前景的積極陳述在實質上是誤導性的，或缺乏合理依據。當真實細節進入市場時，訴訟聲稱投資者遭受了損失。</p>
<p>要加入 Synopsys 集體訴訟，請訪問 https://rosenlegal.com/submit-form/?case_id=44981 https://rosenlegal.com/submit-form/?case_id=39889 或撥打無障礙電話 866-767-3653 聯繫 Phillip Kim 律師，或發送電子郵件至 [email protected] 獲取有關集體訴訟的信息。</p>
<p>尚未認證集體。直到集體被認證之前，您不會被律師代表，除非您自行聘請律師。您可以選擇自己喜歡的律師。您也可以保持缺席集體成員身份，此時無需採取任何行動。投資者分享任何潛在未來賠償的能力並不依賴於擔任首席原告。</p>
<p>請關注我們的 LinkedIn 更新：https://www.linkedin.com/company/the-rosen-law-firm，Twitter：https://twitter.com/rosen_firm 或 Facebook：https://www.facebook.com/rosenlawfirm/。</p>
<p>律師廣告。之前的結果並不保證類似的結果。</p>
<p>聯繫信息：</p>
<p>Laurence Rosen 律師。</p>
<p>Phillip Kim 律師。</p>
<p>羅森律師事務所，P.A.。</p>
<p>275 Madison Avenue, 40th Floor</p>
<p>紐約，NY 10016</p>
<p>電話：（212）686-1060</p>
<p>免費電話：（866）767-3653</p>
<p>傳真：（212）202-3827</p>
<p>[email protected]</p>
<p>www.rosenlegal.com</p>
<p>來源：羅森律師事務所，P.A.。</p>
<p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUxMjAyJk5ld3NJdGVtSWQ9REMzNTUxNyZUcmFuc21pc3Npb25fSWQ9MjAyNTEyMDIxNDQ2UFJfTkVXU19VU1BSX19fX19EQzM1NTE3?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUxMjAyJk5ld3NJdGVtSWQ9REMzNTUxNyZUcmFuc21pc3Npb25fSWQ9MjAyNTEyMDIxNDQ2UFJfTkVXU19VU1BSX19fX19EQzM1NTE3"/></p>

新思科技

<p>羅森律師事務所邀請在 2024 年 12 月 4 日至 2025 年 9 月 9 日期間購買新思科技（Synopsys, Inc.）證券的投資者加入證券欺詐集體訴訟。訴訟指控新思科技對其業務做出了誤導性陳述，特別是在其對人工智能客户的關注方面，這對財務業績產生了負面影響。投資者必須在 2025 年 12 月 30 日之前向法院申請擔任首席原告。羅森律師事務所強調選擇經驗豐富的律師團隊對案件的重要性</p>

<p>, /PRNewswire/ --</p>
<div class="lb-trans"><p>, /PRNewswire/ --</p>
</div><p>Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers and acquirers of Synopsys, Inc. (NASDAQ: SNPS) securities between December 4, 2024 and September 9, 2025, both dates inclusive (the &#34;Class Period&#34;), of the important December 30, 2025 lead plaintiff deadline.</p>
<div class="lb-trans"><p>原因：羅森律師事務所是一家全球投資者權益律師事務所，提醒在 2024 年 12 月 4 日至 2025 年 9 月 9 日期間（包括這兩天）購買和收購 Synopsys, Inc.（納斯達克：SNPS）證券的投資者，注意 2025 年 12 月 30 日的重要首席原告截止日期。</p>
</div><p>So What: If you purchased Synopsys securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.</p>
<div class="lb-trans"><p>那麼，接下來該怎麼辦：如果您購買了 Synopsys 證券，您可能有權在不支付任何自付費用或成本的情況下，通過風險代理安排獲得賠償。</p>
</div><p>What to do next: To join the Synopsys class action, go to https://rosenlegal.com/submit-form/?case_id=44981 https://rosenlegal.com/submit-form/?case_id=39889or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than December 30, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.</p>
<div class="lb-trans"><p>下一步該做什麼：要加入 Synopsys 集體訴訟，請訪問 https://rosenlegal.com/submit-form/?case_id=44981 https://rosenlegal.com/submit-form/?case_id=39889 或撥打無障礙電話 866-767-3653 聯繫 Phillip Kim 律師，或發送電子郵件至 [email protected] 獲取有關集體訴訟的信息。集體訴訟已被提起。如果您希望擔任首席原告，必須在 2025 年 12 月 30 日之前向法院提出申請。首席原告是代表其他集體成員指導訴訟的代表方。</p>
</div><p>Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved, at that time, the largest ever securities class action settlement against a Chinese Company. At the time Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.</p>
<div class="lb-trans"><p>為什麼選擇羅森律師事務所：我們鼓勵投資者選擇在領導角色上有成功記錄的合格律師事務所。通常，發佈通知的事務所沒有相應的經驗、資源或任何有意義的同行認可。這些事務所中的許多並不真正進行證券集體訴訟，而只是作為中介，將客户轉介或與實際進行訴訟的律師事務所合作。選擇律師時要明智。羅森律師事務所代表全球投資者，專注於證券集體訴訟和股東衍生訴訟。羅森律師事務所曾獲得針對一家中國公司的最大證券集體訴訟和解。在 2017 年，羅森律師事務所被 ISS 證券集體訴訟服務評為證券集體訴訟和解數量第一的律師事務所。自 2013 年以來，該事務所每年均排名前四，併為投資者追回了數億美元。僅在 2019 年，該事務所就為投資者爭取了超過 4.38 億美元。在 2020 年，創始合夥人 Laurence Rosen 被 law360 評選為原告律師界的巨頭。該事務所的許多律師已獲得 Lawdragon 和 Super Lawyers 的認可。</p>
</div><p>Details of the Case: According to the lawsuit, defendants throughout the Class Period made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, defendants failed to disclose to investors: (1) the extent to which Synopsys' increased focus on artificial intelligence customers, which require additional customization, was deteriorating the economics of its Design IP business; (2) that, as a result, &#34;certain road map and resource decisions&#34; were unlikely to &#34;yield their intended results,&#34;; (3) that the foregoing had a material negative impact on financial results; and (4) as a result of the foregoing, defendants' positive statements about Synopsys' business, operations, and prospects were materially misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.</p>
<div class="lb-trans"><p>案件詳情：根據訴訟， defendants 在集體訴訟期間做出了實質性虛假和/或誤導性陳述，並未披露有關公司業務、運營和前景的重大不利事實。具體而言，被告未向投資者披露：（1）Synopsys 對人工智能客户的關注增加，導致其設計 IP 業務的經濟狀況惡化的程度；（2）因此，“某些路線圖和資源決策” 不太可能 “產生預期結果”；（3）上述情況對財務結果產生了實質性負面影響；（4）因此，被告對 Synopsys 的業務、運營和前景的積極陳述在實質上是誤導性的，或缺乏合理依據。當真實細節進入市場時，訴訟聲稱投資者遭受了損失。</p>
</div><p>To join the Synopsys class action, go to https://rosenlegal.com/submit-form/?case_id=44981 https://rosenlegal.com/submit-form/?case_id=39889 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.</p>
<div class="lb-trans"><p>要加入 Synopsys 集體訴訟，請訪問 https://rosenlegal.com/submit-form/?case_id=44981 https://rosenlegal.com/submit-form/?case_id=39889 或撥打無障礙電話 866-767-3653 聯繫 Phillip Kim 律師，或發送電子郵件至 [email protected] 獲取有關集體訴訟的信息。</p>
</div><p>No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.</p>
<div class="lb-trans"><p>尚未認證集體。直到集體被認證之前，您不會被律師代表，除非您自行聘請律師。您可以選擇自己喜歡的律師。您也可以保持缺席集體成員身份，此時無需採取任何行動。投資者分享任何潛在未來賠償的能力並不依賴於擔任首席原告。</p>
</div><p>Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.</p>
<div class="lb-trans"><p>請關注我們的 LinkedIn 更新：https://www.linkedin.com/company/the-rosen-law-firm，Twitter：https://twitter.com/rosen_firm 或 Facebook：https://www.facebook.com/rosenlawfirm/。</p>
</div><p>Attorney Advertising. Prior results do not guarantee a similar outcome.</p>
<div class="lb-trans"><p>律師廣告。之前的結果並不保證類似的結果。</p>
</div><p>Contact Information:</p>
<div class="lb-trans"><p>聯繫信息：</p>
</div><p>Laurence Rosen, Esq.</p>
<div class="lb-trans"><p>Laurence Rosen 律師。</p>
</div><p>Phillip Kim, Esq.</p>
<div class="lb-trans"><p>Phillip Kim 律師。</p>
</div><p>The Rosen Law Firm, P.A.</p>
<div class="lb-trans"><p>羅森律師事務所，P.A.。</p>
</div><p>275 Madison Avenue, 40th Floor</p>
<div class="lb-trans"><p>275 Madison Avenue, 40th Floor</p>
</div><p>New York, NY 10016</p>
<div class="lb-trans"><p>紐約，NY 10016</p>
</div><p>Tel: (212) 686-1060</p>
<div class="lb-trans"><p>電話：（212）686-1060</p>
</div><p>Toll Free: (866) 767-3653</p>
<div class="lb-trans"><p>免費電話：（866）767-3653</p>
</div><p>Fax: (212) 202-3827</p>
<div class="lb-trans"><p>傳真：（212）202-3827</p>
</div><p>[email protected]</p>
<div class="lb-trans"><p>[email protected]</p>
</div><p>www.rosenlegal.com</p>
<div class="lb-trans"><p>www.rosenlegal.com</p>
</div><p>SOURCE THE ROSEN LAW FIRM, P. A.</p>
<div class="lb-trans"><p>來源：羅森律師事務所，P.A.。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUxMjAyJk5ld3NJdGVtSWQ9REMzNTUxNyZUcmFuc21pc3Npb25fSWQ9MjAyNTEyMDIxNDQ2UFJfTkVXU19VU1BSX19fX19EQzM1NTE3" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=DC35517&amp;Transmission_Id=202512021446PR_NEWS_USPR_____DC35517&amp;DateId=20251202"/></p>

新思科技公司（Synopsys, Inc.）的投資者有機會主導證券欺詐訴訟